Infliximab receives 13th approval

The risks of poor health, more health care needs, and gynecological cancer are significantly increased in patients with disabilities.

Drug Topics recently sat down with Steve Hoffart, PharmD, owner and PIC at Magnolia Pharmacy north of Houston, to discuss the importance of pharmacists getting involved in advocacy.

A Q&A with Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP, director of education and training in diabetes technology at the Cleveland Clinic.

Todd Eury of the Pharmacy Podcast Network is joined by Josh Bolin of the NABP to talk about DSCSA, what benefits it will provide, and how to make sure your pharmacy is ready when it goes into effect this November.

Federal guidance from the United States Pharmacopeia characterizes the practice as drug compounding, which pharmacists fear may drive up prices.

Prior research has shown the association between various socioeconomic variables and lower adherence to diabetic retinopathy screening, but few have elaborated on the patient perspective to understand the reason behind this association.